• Am. J. Med. Sci. · Apr 2021

    Review Case Reports

    Medical Management of Advanced Oxalate Nephropathy Secondary to Gastric Bypass Surgery.

    • Tony H Kamel and Natallia Maroz.
    • Department of Medicine, Kettering Medical Center, Dayton, Ohio. Electronic address: tony.kamel@ketteringhealth.org.
    • Am. J. Med. Sci. 2021 Apr 1; 361 (4): 517-521.

    AbstractA 73-year-old Caucasian female with a history of obesity status post Roux-en-Y gastric bypass (RYGB) surgery presented with generalized weakness and was found to have acute kidney injury (AKI) with a creatinine peak of 9.1 mg/dL above her baseline of 1.2 mg/dL, and anemia with hemoglobin 5.7 g/dl. Kidney biopsy revealed oxalate nephropathy likely related to gastric bypass surgery four years prior. RYGB is a strong risk factor for hyperoxaluria, nephrolithiasis, and oxalate nephropathy which often progresses to end-stage renal disease (ESRD). Meaningful treatment strategies for this disease entity are lacking. We present a case in which dietary and pharmacological management without the use of renal replacement therapy resulted in stabilization of chronic kidney disease (CKD) stage 5 for seven years at the time of this writing.Copyright © 2020 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        

    hide…